drugset / Trial / NCT02193217
A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303
Summary
The purpose of this study is to explore the cardiac pharmacodynamics, safety and tolerability of MT-1303 in healthy subjects.
Timeline
- Start
- —
- Primary completion
- 2014-12
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fingolimod | Small molecule | — | — |
| Subject | amiselimod | Small molecule | — | — |